CA19-9 decrease and overall survival (OS) in the NAPOLI-1 trial of liposomal irinotecan (nal-IRI) ± 5-fluorouracil and leucovorin (5-FU/LV) in metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapy

Li Tzong Chen, Andrea Wang-Gillam, Yan Shen Shan, Teresa Macarulla, Jean Frédéric Blanc, Richard Hubner, Chang Fang Chiu, Gilberto Schwartsmann, Jens Siveke, Pipas J. Marc, Bruce Belanger, Floris de Jong, Khalid Mamlouk, Daniel Von Hoff

研究成果: Article同行評審

原文English
頁(從 - 到)iii6-iii7
期刊Annals of oncology : official journal of the European Society for Medical Oncology
28
DOIs
出版狀態Published - 2017 六月 1

All Science Journal Classification (ASJC) codes

  • 血液學
  • 腫瘤科

引用此